CLINICAL_TRIALS
trial_result
· 2021-10-12
Clinical Trial Update: Safety and Efficacy Study in Infant With SBS [Phase 2, Phase 3]
Summary
A safety and efficacy study in infants with Short Bowel Syndrome (Phase 2/3) was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Elgan Pharma Ltd. | Conditions: Short Bowel Syndrome | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2021-10-12